Results 101 to 110 of about 14,437,638 (295)
Pancreatic Panniculitis as the First Presentation of Pancreatic Adenocarcinoma
JEADV Clinical Practice, EarlyView.
Claudine Howard‐James +2 more
wiley +1 more source
Small, EarlyView.Force‐driven microneedles are presented as active therapeutic microdevices that overcome the diffusion limits of conventional patches. By integrating gas generation, magnetic actuation, cavitation, or iontophoresis, these systems drive payloads deeper into tissue, enabling faster, more controlled delivery and highlighting key design principles and ...
Majed Amini +3 more
wiley +1 more source
Smart Molecules, EarlyView.The CD47–SIRPα axis has emerged as a critical innate immune checkpoint that suppresses macrophage‐mediated phagocytosis through a canonical “don't eat me” signal and enables tumor immune evasion. We comprehensively summarize the structural and biological features of CD47 and the molecular mechanisms underlying CD47‐mediated regulation of phagocytosis ...
Ruimei Zhou +4 more
wiley +1 more source
Peripheral T cell lymphoma: clinical utility of romidepsin
, 2012 Jasmine Zain, Kathryn SaweyNYU Langone Medical Center, New York, USAIntroduction: Direct therapeutic targets, such as aberrant tumor cell genes and tumor cell markers, have been the focus of cancer treatment for more than 50 years.
Zain J, Sawey K
core
VIEW, EarlyView.Lymphoma is a group of blood cancers that can appear in lymph nodes, blood, bone marrow, spleen, liver, or the central nervous system, which makes drug delivery and disease monitoring difficult. This review summarizes how nanomedicine technologies may improve targeted treatment and imaging, while carefully separating approved or guideline‐supported ...
Mohd Ahmar Rauf +5 more
wiley +1 more source
The Inverse Koebner Phenomenon in Cutaneous T‐Cell Lymphomas
JEADV Clinical Practice, EarlyView.
Alba Guglielmo +3 more
wiley +1 more source
The Journal of Dermatology, EarlyView.ABSTRACT Topical bexarotene 1% gel is an approved skin‐directed treatment for refractory or persistent stage IA‐IB cutaneous T‐cell lymphoma, but real‐world evidence in mycosis fungoides (MF), particularly regarding maintenance use after complete response, remains limited.
Fatich Memet +6 more
wiley +1 more source
A Response to “The Inverse Koebner Phenomenon in Cutaneous T‐Cell Lymphomas”
JEADV Clinical Practice, EarlyView.
Isabel Hariri +2 more
wiley +1 more source
Advances in γδ T Cells: Cutaneous Biology and Therapeutic Potential for Skin Neoplasms
The Journal of Dermatology, EarlyView.ABSTRACT γδ T cells represent an increasingly important subset of T lymphocytes in the immune response to cancer and as a platform for novel immunotherapies. The aim of this review is to synthesize recent insights into the biology and advances in therapeutic applications of γδ T cells in cutaneous malignancies, especially melanoma, within a framework ...
Simo Du +9 more
wiley +1 more source
Cutaneous T-Cell Lymphoma: Two Faces of the Same Coin [PDF]
, 2010 Primary cutaneous anaplastic large-cell lymphoma (C-ALCL) and cutaneous peripheral T-cell lymphoma not otherwise specified (C-PTL-NOS) are cutaneous T-cell lymphomas with distinct clinical behaviors. Whereas C-ALCL has a favorable prognosis with frequent
Wozniak, Magdalena B., Piris, Miguel Á.
core +1 more source